Wedbush Reiterates “Outperform” Rating for IDEAYA Biosciences (NASDAQ:IDYA)
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Wedbush in a report released on Tuesday,Benzinga reports. They currently have a $52.00 price objective on the stock. Wedbush’s price target would indicate a potential upside of 99.62% from the stock’s previous close. Other research analysts also […]
More Stories
scPharmaceuticals Provides Preliminary Financial Results for Fourth Quarter and Full Year 2024On January 10, 2025, scPharmaceuticals Inc. (NASDAQ: SCPH) released an 8-K filing containing preliminary unaudited financial information for the quarter and
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
TJX Companies (NYSE:TJX) Given New $151.00 Price Target at UBS Group
TJX Companies (NYSE:TJX – Free Report) had its target price raised by UBS Group from $148.00 to $151.00 in a...
SolarEdge Technologies’ (SEDG) Sell Rating Reiterated at Citigroup
Citigroup reiterated their sell rating on shares of SolarEdge Technologies (NASDAQ:SEDG – Free Report) in a report issued on Wednesday,...
BHP Group (NYSE:BHP) Upgraded to Strong-Buy at StockNews.com
StockNews.com upgraded shares of BHP Group (NYSE:BHP – Free Report) from a buy rating to a strong-buy rating in a...
ORG Wealth Partners LLC Has $53,000 Holdings in Seagate Technology Holdings plc (NASDAQ:STX)
ORG Wealth Partners LLC cut its position in Seagate Technology Holdings plc (NASDAQ:STX – Free Report) by 24.3% during the...
Aris Water Solutions, Inc. (NYSE:ARIS) Insider Sells $8,332,513.96 in Stock
Aris Water Solutions, Inc. (NYSE:ARIS – Get Free Report) insider S Corp Gable sold 331,181 shares of the business’s stock...